NCT05718778View on ClinicalTrials.gov

Piamprilizumab (AK105) Combined With Radiotherapy for Neoadjuvant Treatment of Soft Tissue Sarcoma

NARecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Soft Tissue Sarcoma
Interventions
DRUG

Piamprimab (AK105)

Piamprilizumab (AK105) combined with radiotherapy for neoadjuvant treatment of soft tissue sarcoma

Trial Locations (1)

450008

RECRUITING

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors
lead

Henan Cancer Hospital

OTHER_GOV